Stephen E Langabeer (S E Langabeer, Stephen Langabeer)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 43

Top Topics

Stem Cell Transplantation

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

Case reports in hematology

Journal of clinical pathology

Irish journal of medical science

American journal of clinical pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen E Langabeer
Noncanonical CALR variants. American journal of clinical pathology 161 (5) (2024)
Stephen E Langabeer
Noncanonical CALR variants. American journal of clinical pathology 161 (5) (2024)
Danielle Patchell, Clodagh Keohane, Susan O'Shea, Stephen E Langabeer
Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics. Journal of clinical pathology (2024)
Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Marie Hvelplund Kristiansen, Troels Wienecke, Sabrina Cordua, Christina Ellervik, Stephen E Langabeer, Hans Carl Hasselbalch
Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP. Molecular diagnosis & therapy (2024)
Stephen E Langabeer
Pyoderma gangrenosum and myeloproliferative neoplasms. Clinical and experimental dermatology (2023)
Stephen E Langabeer
BCR::ABL1 screening is not indicated in patients with splenomegaly without neutrophilia and/or basophilia. Journal of clinical pathology (2023)
Stephen E Langabeer, Stuart Macleod, Úna Bhreathnach, Kamal Fadalla
Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation. Case reports in hematology 2023 (2023)
Stephen E Langabeer
The JAK2 V617F mutation and childhood type1 diabetic nephropathy? Biomedical chromatography : BMC (2023)
Stephen E Langabeer, Stuart Macleod, Úna Bhreathnach, Kamal Fadalla
Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation. Case reports in hematology 2023 (2023)
Stephen E Langabeer
Dual Drivers in the Myeloproliferative Neoplasms: An Underestimation? Technology in cancer research & treatment 22 (2023)
Stephen E Langabeer, Alfred Jones, Eibhlin Conneally, Helen Enright, Philip Murphy, Kanthi Perera, John Quinn, Patrick Thornton
Frequency and driver mutation diversity of concomitant chronic myeloid leukemia and Philadelphia chromosome-negative myeloproliferative neoplasm. International journal of hematology (2023)
Claire Andrews, Eibhlin Conneally, Stephen E Langabeer
Molecular diagnostic criteria of myeloproliferative neoplasms. Expert review of molecular diagnostics (2023)
Stephen E Langabeer, Áine Burke
Persisting with persistent thrombocytosis. International journal of laboratory hematology (2023)
Stephen E Langabeer
Noncanonical CALR variants. American journal of clinical pathology (2023)
Stephen E Langabeer
Testosterone, erythrocytosis and the JAK2 V617 F mutation. Annals of clinical biochemistry 59 (3) (2022)
Stephen E Langabeer
Molecular screening for an underlying myeloproliferative neoplasm in rheumatology patients. Archives of rheumatology 37 (3) (2022)
Stephen E Langabeer
Molecular screening for an underlying myeloproliferative neoplasm in rheumatology patients. Archives of rheumatology 37 (3) (2022)
Lisa Lee Tokar, Laura Kearney, Stephen E Langabeer
MPL exon 10 mutations in Irish patients with a suspected myeloproliferative neoplasm. EXCLI journal 20 (2021)
Rehman Faryal, Lisa Lee Tokar, Stephen E Langabeer, Janusz Krawczyk
CALR Mutation Underlying Silent Stroke. TH open : companion journal to thrombosis and haemostasis 5 (2) (2021)
Úna Bhreathnach, Stephen E Langabeer
Quantification of atypical BCR-ABL1 fusion transcripts in patients with chronic myeloid leukemia: Which approach for harmonization? International journal of laboratory hematology (2021)
Stephen E Langabeer
The eosinophilic variant of chronic myeloid leukemia. EXCLI journal 20 (2021)
Stephen E Langabeer, David O'Brien, Sarah McCarron, C Larry Bacon, Elisabeth Vandenberghe
Real-world experience of BRAF V600E mutation testing in hairy cell leukaemia. Journal of clinical pathology 74 (12) (2020)
Stephen E Langabeer, Rehman Faryal, Michael O'Dwyer, Sorcha Ní Loingsigh
Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia. Case reports in hematology 2020 (2020)
Stephen E Langabeer, Lisa Lee Tokar, Laura Kearney, Cathal O'Brien, Kowshika Thavarajah, Aisling Barrett, John McManus, Hilary O'Leary
Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation. Case reports in hematology 2020 (2020)
Laura Kearney, Lisa Lee Tokar, Catherine Flynn, Vitaliy Mykytiv, Karen Murphy, Stephen E Langabeer
Repeat JAK2 V617F testing in patients with suspected essential thrombocythaemia. Journal of clinical pathology 73 (11) (2020)
Stephen E Langabeer
Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic. Irish journal of medical science 190 (1) (2020)
Stephen E Langabeer
No indication for CALR mutation analysis in Irish patients presenting with deep vein thrombosis or pulmonary embolism. Irish journal of medical science 188 (4) (2019)
Rachel Brodie, Stephen E Langabeer, John Quinn, Máirín E McMenamin, Patrick J Hayden
Sorafenib for relapsed FLT3-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis. Clinical case reports 7 (12) (2019)
Louisa Shackleton, Stephen E Langabeer, David O'Brien, Sarah L McCarron, Bridgette Byrne, Rupert Barry, Richard Flavin, C Larry Bacon, Catherine M Flynn
Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy. Case reports in hematology 2019 (2019)
Mireille Crampe, Laura Kearney, David O'Brien, C Larry Bacon, Derville O'Shea, Stephen E Langabeer
Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion. Case reports in hematology 2019 (2019)
Stephen E Langabeer
The JAK2 V617F mutation in breast cancer? The breast journal 26 (3) (2019)
Stephen E Langabeer, Mireille Crampe, Tara Durney
The impact of sample processing delay on deep molecular responses in chronic myeloid leukemia. Irish journal of medical science 188 (1) (2018)
Stephen E Langabeer, Karl Haslam, Maria Anne Smyth, John Quinn, Philip T Murphy
Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia. Case reports in hematology 2018 (2018)
Stephen E Langabeer
Reflective molecular testing for myeloproliferative neoplasms in patients with elevated serum vitamin B12. Annals of clinical biochemistry 55 (6) (2018)
Stephen E Langabeer
Double-mutant myeloproliferative neoplasms. Medical oncology (Northwood, London, England) 35 (10) (2018)
Stephen E Langabeer, Eibhlin Conneally, Catherine M Flynn
Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis. Case reports in hematology 2018 (2018)
Stephen E Langabeer
Aquagenic pruritus and the JAK2 V617F mutation. Clinical and experimental dermatology 44 (3) (2018)
Stephen E Langabeer, Lisa Preston, Johanna Kelly, Matt Goodyer, Ezzat Elhassadi, Amjad Hayat
Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia. Case reports in hematology 2017 (2017)
Mireille Crampe, Claire Andrews, Anne Fortune, Stephen E Langabeer
Late Emergence of an Imatinib-Resistant ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia. Case reports in hematology 2017 (2017)
Stephen E Langabeer, Karl Haslam, Emma Groarke, Eibhlin Conneally
An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis. British journal of haematology 183 (2) (2017)
Stephen E Langabeer, K Haslam, J Kelly, J Quinn, R Morrell, E Conneally
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (3) (2017)
Mireille Crampe, Karl Haslam, Emma Groarke, Eileen Kelleher, Derville O'Shea, Eibhlin Conneally, Stephen E Langabeer
Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring. Case reports in hematology 2017 (2017)
Karl Haslam, Stephen E Langabeer
Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches. BioMed research international 2016 (2016)